These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
656 related items for PubMed ID: 24436135
21. Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease. Tanaka M, Namiki C, Thuy DH, Yoshida H, Kawasaki K, Hashikawa K, Fukuyama H, Kita T. J Neurol Sci; 2004 Oct 15; 225(1-2):135-41. PubMed ID: 15465097 [Abstract] [Full Text] [Related]
26. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group. Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, Nishimura T. Dement Geriatr Cogn Disord; 2000 Oct 15; 11(6):299-313. PubMed ID: 11044775 [Abstract] [Full Text] [Related]
29. Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses. Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown RG, Banerjee S, Adams J, Johnson T, Bentham P, Phillips PP. Lancet Neurol; 2015 Dec 15; 14(12):1171-81. PubMed ID: 26515660 [Abstract] [Full Text] [Related]
36. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients? Sevilla C, Jiménez Caballero PE, Alfonso V, González-Adalid M. Dement Geriatr Cogn Disord; 2009 May 15; 28(3):196-205. PubMed ID: 19738386 [Abstract] [Full Text] [Related]
37. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R. Dement Geriatr Cogn Disord; 2006 May 15; 21(5-6):353-63. PubMed ID: 16508298 [Abstract] [Full Text] [Related]
39. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease. Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R, AWARE Study Group. CNS Drugs; 2006 May 15; 20(4):311-25. PubMed ID: 16599649 [Abstract] [Full Text] [Related]
40. Donepezil and memantine for moderate-to-severe Alzheimer's disease. Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P. N Engl J Med; 2012 Mar 08; 366(10):893-903. PubMed ID: 22397651 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]